• Meryllion Resources Corporation (MYR) has closed a non-brokered private placement for gross proceeds of $100,000
  • The corporation issued a total of 2,000,000 units at a price of $0.05 per unit
  • Meryllion Resources is an exploration and development company
  • Meryllion Resources Corp. (MYR) opened trading at C$0.02

Meryllion Resources Corporation (MYR) has closed a non-brokered private placement for gross proceeds of $100,000.

The corporation issued a total of 2,000,000 units at a price of $0.05 per unit. Each unit consists of one common share and one common share purchase warrant. Each warrant entitles the holder to acquire an additional common share at a price of $0.08 per share at any time up until July 1, 2023.

The proceeds will be used for working capital purposes.

Mr. David Steinepreis, a director of the corporation, purchased all of the units issued through Croesus Mining Pty Ltd.

All securities issued are subject to a statutory hold period of four months.

Meryllion Resources is an exploration and development company focused on mineral exploration, mine development, and finance opportunities in Tier 1 jurisdictions, where the company can earn interest by funding exploration. The company is in the process of earning up to a 70 per cent interest in the Mt Turner copper-molybdenum-gold and uranium project in north Queensland and has an option over the Oldham Range Polymetallic Project located 320kms west of Wiluna, Western Australia.

Meryllion Resources Corp. (MYR) opened trading at C$0.02.


More From The Market Online

Three stocks with multi-bagger potential

The best investors stick to stocks with the most easily discernible reasons in support of their multi-bagger potential.

Junior gold CEO signals conviction with new investment

Cynthia Le Sueur-Aquin, CEO of junior gold stock Laurion Mineral Exploration (TSXV:LME), will exercise 750,000 stock options for C$142,500.

PharmAla Biotech launches educational portal for MDMA

PharmAla Biotech (CSE:MDMA) launches its Prescribers Portal for medical practitioners to learn more about MDMA.